Non-Performing Assets / Total Loans (Annual)

Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made

Gilead Sciences, Inc. (GILD) Non-Performing Assets / Total Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$27.12B
Net Income	$5.67B
Cost of Goods Sold	$6.50B
Gross Profit	$20.62B
Operating Expenses	$19.51B
Operating Income	$7.61B
Non-Operating Income/Expense	$-746.00M
Pre-Tax Income	$6.86B
Normalized Pre-Tax Income	$6.86B
Income after Taxes	$5.61B
Income from Continuous Operations	$5.61B
Consolidated Net Income/Loss	$5.61B
Normalized Income after Taxes	$5.61B
EBIT	$7.61B
EBITDA	$10.30B
Weighted-Average Shares Outstanding (Basic)	1.25B
Weighted-Average Shares Outstanding (Diluted)	1.26B
Earnings per Share (EPS) (Basic)	$4.54
Earnings per Share (EPS) (Diluted)	$4.50
Balance Sheet Financials
Current Assets	$16.09B
Property, Plant, and Equipment	$5.32B
Long-Term Assets	$46.04B
Total Assets	$62.12B
Current Liabilities	$11.28B
Long-Term Debt	$24.47B
Long-Term Liabilities	$28.10B
Total Liabilities	$39.38B
Common Equity	$22.75B
Tangible Shareholders Equity	$-12.02B
Shareholders Equity	$22.75B
Common Shares Outstanding	1.25B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$8.01B
Cash Flow from Investing Activities	$-2.27B
Cash Flow from Financial Activities	$-5.12B
Beginning Cash	$5.41B
End Cash	$6.08B
Increase/Decrease in Cash	$673.00M
Stock-Based Compensation	$766.00M
Common Stock Dividends Paid	$-3.81B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.43
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.52
Debt to Equity Ratio	1.15
Gross Margin	76.04%
Operating Margin	28.05%
EBIT Margin	28.05%
EBITDA Margin	37.98%
Pre-Tax Profit Margin	25.30%
Profit Margin	20.89%
Free Cash Flow	$7.42B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.44
Inventory Turnover	3.64
Receiveable Turnover	5.82
Days Sales in Receivables	62.73
Return on Equity	24.67%
Return on Tangible Equity	-46.69%
Return on Assets	9.03%
Return on Investments	11.89%
Book Value Per Share	$18.26
Free Cash Flow per Share	$5.90
Operating Cash Flow per Share	$6.36

Data from Zacks Investment Research, Inc.